Cardiovascular Disease

Cardiovascular disease involves the heart and vessels and is the number one killer in the U.S. accounting for nearly 30-percent of all deaths. Cardiovascular disease has a number of forms but the most common are myocardial infarction and angina pectoris which affect the heart itself.

What is Cardiovascular Disease?

Diseases of disorders of this system are termed cardiovascular diseases. Cardiovascular diseases kill an estimated 17 million people worldwide each year. Majority of these are due to heart attacks and strokes.

Cardiovascular Disease Research

Causes and Symptoms of Hypoplastic Left Heart Syndrome

Cardiovascular Drugs

Lowering Risk for Cardiovascular Disease

Non-Communicable Diseases

Cardiovascular Disease Diagnosis

Cardiovascular Benefits of Blueberries

What is Microvascular Endothelial Dysfunction?

Latest Cardiovascular Disease News and Research

Polyphenol-rich dietary patterns linked to lower cardiovascular disease risk

People who regularly consume polyphenol-rich foods and drinks, such as tea, coffee, berries, cocoa, nuts, whole grains and olive oil, may have better long-term heart health.

27 Nov 2025

EACVI 2025 brings cardiac imaging experts together in Vienna

The European Association of Cardiovascular Imaging (EACVI), a branch of the European Society of Cardiology (ESC), will hold its flagship event, EACVI 2025, in Vienna, Austria from 11-13 December.

26 Nov 2025

New report outlines recommendations to improve chronic disease care for Latinos

Latinos face significant health disparities, especially in chronic conditions such as cardiovascular disease, diabetes, asthma, and cancer.

24 Nov 2025

Higher teen blood pressure predicts who develops heart disease

A study reveals that adolescent blood pressure levels are strong predictors of coronary atherosclerosis, emphasizing the importance of monitoring in youth.

24 Nov 2025

American Heart Association honors schools and students for fighting childhood obesity

One in every five American children and teens is obese; that's up 35% from 2000, as severe childhood obesity rates have nearly doubled in that time.

22 Nov 2025

Study highlights limitations of current cardiac screening tools

Current cardiac screening tools used to prevent heart attacks fail to identify nearly half of the people who are actually at risk of having one, according to a new study led by Mount Sinai researchers.

22 Nov 2025

Digital and AI innovations in cardiology take center stage at ESC Digital & AI Summit

Smartphone stethoscopes, voice-detected heart failure, training using 3D-printed and virtual hearts and early detection of cardiovascular disease using blood spots are among the innovations being presented at the ESC Digital & AI Summit taking place in Berlin, Germany, 21–22 November.

21 Nov 2025

Ultraprocessed diets affect teens and young adults differently

A study reveals that adolescents consume more calories on ultraprocessed diets, highlighting a critical vulnerability in modern food environments.

21 Nov 2025

CAR T cell therapy could be a highly effective tool against atherosclerosis

A pioneering preclinical study has shown that CAR T cell therapy-a personalized form of immunotherapy used in cancer treatment-could be a highly effective tool against atherosclerosis, the condition where a build-up of plaque in the arteries reduces blood flow, leading to heart attacks and strokes.

21 Nov 2025

Even one cigarette a day harms the heart at every level

Smoking elevates heart disease and mortality risks. Cessation initiates a powerful recovery, reducing risks significantly within two decades.

21 Nov 2025

Eating lean beef as part of MED diet could improve gut diversity

Incorporating lean beef into a Mediterranean diet reduces TMAO levels and improves gut health, highlighting the importance of dietary patterns for wellness.

21 Nov 2025

Evidence links severe gum disease to erectile dysfunction and broader men’s health risks

A healthy mouth is also key to a healthy body, as gum disease has been linked to non-communicable diseases such as diabetes, cardiovascular disease, rheumatoid arthritis and Alzheimer's.

20 Nov 2025

Study compares the kidney, cardiovascular and mortality risks of three different GLP-1 RAs

Public interest in drugs known as glucagon-like peptide-1 receptor agonists, also called GLP-1 RAs, has surged in recent years, with popular types like semaglutide (sold under brand names like Ozempic and Wegovy) becoming known for their weight-loss effects.

20 Nov 2025

Even minimal cigarette use significantly increases heart disease and mortality risk

Smoking even 2-5 cigarettes a day can more than double your risk of any type of heart disease and raise your risk of death from any cause by 60% compared to people who never smoked, according to new research supported by the American Heart Association's Tobacco Center for Regulatory Science and published in PLOS Medicine.

19 Nov 2025

High blood pressure in adolescence can be linked to atherosclerosis risk in middle age

A blood pressure as low as 120/80 mm Hg in adolescence can be linked to a higher risk of atherosclerosis in middle age, according to a study led from Linköping University, Sweden.

19 Nov 2025

Lean beef fits safely into a Mediterranean diet without raising heart disease risk

Eating moderate amounts of lean beef as part of a Mediterranean diet does not increase an emerging risk factor for cardiovascular disease, according to a new study by an interdisciplinary research team at Penn State.

19 Nov 2025

Current genetic screening guidelines overlook most cases of familial hypercholesterolemia

Current genetic screening guidelines fail to identify most people with an inherited condition known as familial hypercholesterolemia that can cause dangerously high cholesterol and early heart disease, a Mayo Clinic study found.

19 Nov 2025

Coffee protects the brain, metabolism, and immunity at the molecular level

This review uncovers the molecular networks of coffee's compounds, showcasing their antioxidant and neuroprotective effects on immunity and metabolism.

19 Nov 2025

Oral semaglutide delivers real-world drops in blood sugar and weight in diabetes trial

Oral semaglutide delivered meaningful reductions in HbA1c and body weight among GLP-1RA-naïve adults with type 2 diabetes in a Dutch real-world cohort. Lipid levels and blood pressure showed only small changes, reflecting modest cardiometabolic effects outside glucose and weight control.

18 Nov 2025

Experts call for bold policies to curb the health harms of ultra-processed foods

The increase of UPFs in diets worldwide presents an urgent challenge to health that demands coordinated policies and advocacy action to address, says a new three paper Series authored by 43 global experts and published in The Lancet. The Series exposes the tactics UPF companies use to drive consumption and prevent effective policy.

18 Nov 2025